SOPH 3.52 (+3.53%)
CH1125843347• Healthcare Providers & Services• Health Information Services
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. SOPH

Sophia Genetics (SOPH) Competitor Comparison

We are evaluating the key criteria listed to compare Sophia Genetics (SOPH) against its competitors in the Health Information Services industry.

Market Capitalization

24 / 35

Gross Profits

27 / 31

Total Revenue

28 / 33

EBITDA

28 / 33

Free Cashflow

29 / 34

Quick Ratio

10 / 34

Earnings per Share

24 / 33

Dividend yield

0 / 3

Total Cash

20 / 34

Performance 3 years

22 / 35

Performance 5 years

26 / 35

Performance 10 years

27 / 35

Linearity 3 years

23 / 35

Linearity 5 years

29 / 35

Linearity 10 years

27 / 35

Total Rank

26 / 35

Dividend Rank

20 / 35

Valuation Rank

2 / 35

Piotroski Rank

22 / 35

Muliplier Rank

33 / 35

Muliplier Rank - SOPH ranking 33 / 35

These are the competitors of Sophia Genetics in the industry Health Information Services ranked by muliplier rank
1. Teladoc Health TDOC
1
2. ZHONGCHAO ZCMD
0.6
3. Agiliti AGTI
0.6
4. Allscripts Healthcare Solutions MDRX
0.6
5. CareCloud MTBC
0.6
6. CareMax CMAX
0.6
7. Covetrus CVET
0.6
8. HeartBeam BEAT
0.6
9. icad ICAD
0.6
10. NantHealth NH
0.6
11. Premier Inc PINC
0.6
12. Omnicell OMCL
0.5
13. Evolent Health EVH
0.2
14. Forian FORA
0.2
15. GoodRx Holdings GDRX
0.2
16. Healthcare Triangle HQY
0.2
17. Tabula Rasa HealthCare TRHC
0.2
18. 1Life Healthcare ONEM
0.2
19. iCoreConnect ICCT
0.2
20. Veeva Systems VEEV
0.2
21. NextGen Healthcare NXGN
0.2
22. OptimizeRx OPRX
0.2
23. Phreesia PHR
0.2
24. 10x Genomics TXG
0.2
25. Privia Health Group PRVA
0.2
26. Accolade ACCD
0.2
27. Progyny PGNY
0.2
28. Signify Health SGFY
0.2
29. Augmedix AUGX
0.2
30. Simulations Plus SLP
0.2
31. SomaLogic SLGC
0.2
32. Change Healthcare CHNG
0.2
33. Sophia Genetics SOPH
0.2
34. Doximity DOCS
0.2
35. Definitive Healthcare DH
0.2
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.